These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38960987)

  • 1. Pyroptosis-related long-noncoding RNA signature predicting survival and immunotherapy efficacy in patients with lung squamous cell carcinoma.
    Zhan X; Li J; Ding Y; Zhou F; Zeng R; Lei L; Zhang Y; Feng A; Qu Y; Yang Z
    Clin Exp Med; 2024 Jul; 24(1):145. PubMed ID: 38960987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.
    Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L
    Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel disulfidptosis-related LncRNA prognostic risk model: predicts the prognosis, tumor microenvironment and drug sensitivity in esophageal squamous cell carcinoma.
    Ye C; Xu C; Tang Y; Qi Y; Peng X; Wei G; Jiang L
    BMC Gastroenterol; 2024 Nov; 24(1):437. PubMed ID: 39604874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of ELF1 combined with MMP9 is associated with prognosis and tumor microenvironment in gastric cancer.
    Zhang X; Ren X; Zhang S; Wang Y
    Exp Ther Med; 2024 Dec; 28(6):441. PubMed ID: 39583246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualitative evidence synthesis informing our understanding of people's perceptions and experiences of targeted digital communication.
    Ryan R; Hill S
    Cochrane Database Syst Rev; 2019 Oct; 10(10):ED000141. PubMed ID: 31643081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Exploration of key ferroptosis-related genes as therapeutic targets for sepsis based on bioinformatics and the depiction of their immune profiles characterization].
    Li M; Mei Y; Pan A
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 Oct; 36(10):1025-1032. PubMed ID: 39586719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antioxidants for female subfertility.
    Showell MG; Mackenzie-Proctor R; Jordan V; Hart RJ
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD007807. PubMed ID: 32851663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deciphering potential molecular mechanisms in clear cell renal cell carcinoma based on the ubiquitin-conjugating enzyme E2 related genes: Identifying UBE2C correlates to infiltration of regulatory T cells.
    Feng X; Wang Z; Cen M; Zheng Z; Wang B; Zhao Z; Zhong Z; Zou Y; Lv Q; Li S; Huang L; Huang H; Qiu X
    Biofactors; 2024 Nov; ():. PubMed ID: 39614426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genedrive kit for detecting single nucleotide polymorphism m.1555A>G in neonates and their mothers: a systematic review and cost-effectiveness analysis.
    Shabaninejad H; Kenny RP; Robinson T; Stoniute A; O'Keefe H; Still M; Thornton C; Pearson F; Beyer F; Meader N
    Health Technol Assess; 2024 Oct; 28(75):1-75. PubMed ID: 39487741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forkhead box N1 is possibly a novel biomarker and prognostic indicator for patients with squamous cell lung carcinoma.
    Wang X; Zhang C; Duan BJ; Bai J; Li T; Dong XY; Li EX
    Int J Med Sci; 2024; 21(15):3058-3068. PubMed ID: 39628682
    [No Abstract]   [Full Text] [Related]  

  • 12. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
    Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
    Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.
    Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B
    Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of malic enzyme 1 predicts adverse prognosis in patients with cytogenetically normal acute myeloid leukaemia and promotes leukaemogenesis through the IL-6/JAK2/STAT3 pathways.
    Zhang C; Li W; Wu F; Lu Z; Zeng P; Luo Z; Cao Y; Wen F; Li J; Chen X; Wang F
    Ther Adv Hematol; 2024; 15():20406207241301948. PubMed ID: 39610460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of prediction models for fetal growth restriction and birthweight: an individual participant data meta-analysis.
    Allotey J; Archer L; Coomar D; Snell KI; Smuk M; Oakey L; Haqnawaz S; Betrán AP; Chappell LC; Ganzevoort W; Gordijn S; Khalil A; Mol BW; Morris RK; Myers J; Papageorghiou AT; Thilaganathan B; Da Silva Costa F; Facchinetti F; Coomarasamy A; Ohkuchi A; Eskild A; Arenas Ramírez J; Galindo A; Herraiz I; Prefumo F; Saito S; Sletner L; Cecatti JG; Gabbay-Benziv R; Goffinet F; Baschat AA; Souza RT; Mone F; Farrar D; Heinonen S; Salvesen KÅ; Smits LJ; Bhattacharya S; Nagata C; Takeda S; van Gelder MM; Anggraini D; Yeo S; West J; Zamora J; Mistry H; Riley RD; Thangaratinam S
    Health Technol Assess; 2024 Aug; 28(47):1-119. PubMed ID: 39252507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Develop a Novel Signature to Predict the Survival and Affect the Immune Microenvironment of Osteosarcoma Patients: Anoikis-Related Genes.
    Yang M; Su Y; Xu K; Zheng H; Cai Y; Wen P; Yang Z; Liu L; Xu P
    J Immunol Res; 2024; 2024():6595252. PubMed ID: 39431237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological treatments in panic disorder in adults: a network meta-analysis.
    Guaiana G; Meader N; Barbui C; Davies SJ; Furukawa TA; Imai H; Dias S; Caldwell DM; Koesters M; Tajika A; Bighelli I; Pompoli A; Cipriani A; Dawson S; Robertson L
    Cochrane Database Syst Rev; 2023 Nov; 11(11):CD012729. PubMed ID: 38014714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies to improve smoking cessation rates in primary care.
    Lindson N; Pritchard G; Hong B; Fanshawe TR; Pipe A; Papadakis S
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD011556. PubMed ID: 34693994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the SORG Machine-learning Algorithm for Extremity Metastases Generalize to a Contemporary Cohort of Patients? Temporal Validation From 2016 to 2020.
    de Groot TM; Ramsey D; Groot OQ; Fourman M; Karhade AV; Twining PK; Berner EA; Fenn BP; Collins AK; Raskin K; Lozano S; Newman E; Ferrone M; Doornberg JN; Schwab JH
    Clin Orthop Relat Res; 2023 Dec; 481(12):2419-2430. PubMed ID: 37229565
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.